164 related articles for article (PubMed ID: 38139182)
21. Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.
Guénard S; Muller C; Monlezun L; Benas P; Broutin I; Jeannot K; Plésiat P
Antimicrob Agents Chemother; 2014; 58(1):221-8. PubMed ID: 24145539
[TBL] [Abstract][Full Text] [Related]
22. Expression of the MexXY Aminoglycoside Efflux Pump and Presence of an Aminoglycoside-Modifying Enzyme in Clinical Pseudomonas aeruginosa Isolates Are Highly Correlated.
Seupt A; Schniederjans M; Tomasch J; Häussler S
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046496
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional and Mutational Profiling of an Aminoglycoside-Resistant Pseudomonas aeruginosa Small-Colony Variant.
Schniederjans M; Koska M; Häussler S
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874369
[No Abstract] [Full Text] [Related]
24. Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.
Anderson GG; Kenney TF; Macleod DL; Henig NR; O'Toole GA
Pathog Dis; 2013 Feb; 67(1):39-45. PubMed ID: 23620118
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.
Chuanchuen R; Wannaprasat W; Schweizer HP
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450
[TBL] [Abstract][Full Text] [Related]
26. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
27. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
Morita Y; Tomida J; Kawamura Y
Microbiology (Reading); 2012 Apr; 158(Pt 4):1071-1083. PubMed ID: 22282519
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa.
Fraud S; Poole K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1068-74. PubMed ID: 21173187
[TBL] [Abstract][Full Text] [Related]
29. Involvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosa.
Kindrachuk KN; Fernández L; Bains M; Hancock RE
Antimicrob Agents Chemother; 2011 May; 55(5):1874-82. PubMed ID: 21357290
[TBL] [Abstract][Full Text] [Related]
30. Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.
Schurek KN; Marr AK; Taylor PK; Wiegand I; Semenec L; Khaira BK; Hancock RE
Antimicrob Agents Chemother; 2008 Dec; 52(12):4213-9. PubMed ID: 18824604
[TBL] [Abstract][Full Text] [Related]
31. Fosfomycin enhances the active transport of tobramycin in Pseudomonas aeruginosa.
MacLeod DL; Velayudhan J; Kenney TF; Therrien JH; Sutherland JL; Barker LM; Baker WR
Antimicrob Agents Chemother; 2012 Mar; 56(3):1529-38. PubMed ID: 22232284
[TBL] [Abstract][Full Text] [Related]
32. Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin.
Borisova M; Gisin J; Mayer C
Microb Drug Resist; 2014 Jun; 20(3):231-7. PubMed ID: 24819062
[TBL] [Abstract][Full Text] [Related]
33. Contribution of the MexXY multidrug efflux pump and other chromosomal mechanisms on aminoglycoside resistance in Pseudomonas aeruginosa isolates from canine and feline infections.
Poonsuk K; Chuanchuen R
J Vet Med Sci; 2012 Dec; 74(12):1575-82. PubMed ID: 22813987
[TBL] [Abstract][Full Text] [Related]
34. Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in
Mangiaterra G; Cedraro N; Vaiasicca S; Citterio B; Frangipani E; Biavasco F; Vignaroli C
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511375
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of adaptive resistance to aminoglycosides of Pseudomonas aeruginosa].
Hocquet D; El Garch F; Vogne C; Plésiat P
Pathol Biol (Paris); 2003 Oct; 51(8-9):443-8. PubMed ID: 14568587
[TBL] [Abstract][Full Text] [Related]
36. The aminoglycoside resistance-promoting AmgRS envelope stress-responsive two-component system in Pseudomonas aeruginosa is zinc-activated and protects cells from zinc-promoted membrane damage.
Poole K; Hay T; Gilmour C; Fruci M
Microbiology (Reading); 2019 May; 165(5):563-571. PubMed ID: 30835196
[TBL] [Abstract][Full Text] [Related]
37. Natural Alkaloid Berberine Activity against
Laudadio E; Cedraro N; Mangiaterra G; Citterio B; Mobbili G; Minnelli C; Bizzaro D; Biavasco F; Galeazzi R
J Nat Prod; 2019 Jul; 82(7):1935-1944. PubMed ID: 31274312
[TBL] [Abstract][Full Text] [Related]
38. Tobramycin adaptation alters the antibiotic susceptibility of Pseudomonas aeruginosa quorum sensing-null mutants.
Abisado-Duquea RG; McKee BM; Townsend KA; Woods K; Koirala P; Holder AJ; Craddock VD; Cabeen MT; Chandler JR
bioRxiv; 2023 Mar; ():. PubMed ID: 36711731
[TBL] [Abstract][Full Text] [Related]
39. Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.
McCaughey G; Diamond P; Elborn JS; McKevitt M; Tunney MM
PLoS One; 2013; 8(7):e69763. PubMed ID: 23936095
[TBL] [Abstract][Full Text] [Related]
40. The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa.
Castañeda-García A; Rodríguez-Rojas A; Guelfo JR; Blázquez J
J Bacteriol; 2009 Nov; 191(22):6968-74. PubMed ID: 19734311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
